Related references
Note: Only part of the references are listed.Association of working memory and elevated overnight urinary norepinephrine in patients with schizophrenia
Anya Savransky et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
Pro-cognitive effect of 1MeTIQ on recognition memory in the ketamine model of schizophrenia in rats: the behavioural and neurochemical effects
Magdalena Bialon et al.
PSYCHOPHARMACOLOGY (2020)
Maternal Immune Activation Sensitizes Male Offspring Rats to Lipopolysaccharide-Induced Microglial Deficits Involving the Dysfunction of CD200-CD200R and CX3CL1-CX3CR1 Systems
Katarzyna Chamera et al.
CELLS (2020)
Alterations in the Antioxidant Enzyme Activities in the Neurodevelopmental Rat Model of Schizophrenia Induced by Glutathione Deficiency during Early Postnatal Life
Magdalena Gorny et al.
ANTIOXIDANTS (2020)
The role of norepinephrine in the pathophysiology of schizophrenia
Veronica Maki-Marttunen et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Dopamine and Cognitive Control in Prefrontal Cortex
Torben Ott et al.
TRENDS IN COGNITIVE SCIENCES (2019)
Comparison of the effects of 1MeTIQ and olanzapine on performance in the elevated plus maze test and monoamine metabolism in the brain after ketamine treatment
Agnieszka Wasik et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Antimanic activity of minocycline in a GBR12909-induced model of mania in mice: Possible role of antioxidant and neurotrophic mechanisms
Ana Isabelle G. de Queiroz et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Reduced Prepulse Inhibition as a Biomarker of Schizophrenia
Auxiliadora Mena et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2016)
Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View
Jeffrey K. Yao et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder
Judith L. Rapoport et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2011)
Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders
Jeremy W. Gawryluk et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Oxidative stress in schizophrenia: An integrated approach
Byron K. Y. Bitanihirwe et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Acute estrogen treatment facilitates recognition memory consolidation and alters monoamine levels in memory-related brain areas
T. Inagaki et al.
HORMONES AND BEHAVIOR (2010)
Redox dysregulation, neurodevelopment, and schizophrenia
Kim Q. Do et al.
CURRENT OPINION IN NEUROBIOLOGY (2009)
Prepulse inhibition of the startle response with chronic schizophrenia: A replication study
Masatsugu Moriwaki et al.
NEUROSCIENCE RESEARCH (2009)
1-Methyl-1,2,3,4-tetrahydroisoquinoline Antagonizes a Rise in Brain Dopamine Metabolism, Glutamate Release in Frontal Cortex and Locomotor Hyperactivity Produced by MK-801 but not the Disruptions of Prepulse Inhibition, and Impairment of Working Memory in Rat
Malgorzata Pietraszek et al.
NEUROTOXICITY RESEARCH (2009)
Glutamate and dopamine dysregulation in schizophrenia - A synthesis and selective review
James M. Stone et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Transitory glutathione deficit during brain development induces cognitive impairment in juvenile and adult rats:: Relevance to schizophrenia
Jan-Harry Cabungcal et al.
NEUROBIOLOGY OF DISEASE (2007)
Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: A double-blind, randomized controlled trial
Jonathan K. Wynn et al.
SCHIZOPHRENIA RESEARCH (2007)
Altered glutathione redox state in schizophrenia
Jeffrey K. Yao et al.
DISEASE MARKERS (2006)
Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: Relevance to schizophrenia
Jan-Harry Cabungcal et al.
NEUROBIOLOGY OF DISEASE (2006)
Phenotype of schizophrenia: a review and formulation
CA Tamminga et al.
MOLECULAR PSYCHIATRY (2005)
Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit:: relevance to schizophrenia
V Castagné et al.
NEUROBIOLOGY OF DISEASE (2004)
Identification of separable cognitive factors in schizophrenia
KH Nuechterlein et al.
SCHIZOPHRENIA RESEARCH (2004)
An animal model with relevance to schizophrenia: Sex-dependent cognitive deficits in osteogenic disorder-Shionogi rats induced by glutathione synthesis and dopamine uptake inhibition during development
V Castagne et al.
NEUROSCIENCE (2004)
Animal behavior models of the mechanisms underlying antipsychotic atypicality
MA Geyer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia
EJ Duncan et al.
PSYCHOPHARMACOLOGY (2003)
New model of glutathione deficit during development:: Effect on lipid peroxidation in the rat brain
M Rougemont et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Prevalence and incidence studies of schizophrenic disorders: A systematic review of the literature
EM Goldner et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2002)
Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges
NR Swerdlow et al.
PSYCHOPHARMACOLOGY (2001)
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
MA Geyer et al.
PSYCHOPHARMACOLOGY (2001)
WAY 100135, an antagonist of 5-HT1A serotonin receptors, attenuates psychotomimetic effects of MK-801
K Wedzony et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Catching up on schizophrenia: Natural history and neurobiology
DA Lewis et al.
NEURON (2000)
Schizophrenia:: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
KQ Do et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Share Paper
